Discovery of the anthrax toxin: the beginning of studies of virulence determinants regulated in vivo

International Journal of Medical Microbiology - Tập 291 - Trang 411-417 - 2001
Harry Smith

Tài liệu tham khảo

Alouf, 1991 Beall, 1962, Rapid lethal effects in rats of a third component found upon fractionating the toxin of Bacillus anthracis, Bacteriol, 83, 1274, 10.1128/JB.83.6.1274-1280.1962 Belton, 1954, Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and method of production, Brit. J. Exp. Pathol., 35, 144 Campagnari, 1994, Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis, Infect. Immun., 62, 2379, 10.1128/IAI.62.6.2379-2386.1994 Collier, 1975, Diphtheria toxin: mode of action and structure, Bacteriol. Rev., 39, 54, 10.1128/MMBR.39.1.54-85.1975 Cromartie, 1947, Studies on infection with Bacillus anthracis I. A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species, J. Infect. Dis., 80, 1, 10.1093/infdis/80.1.1 Cromartie, 1947, Studies on infection with Bacillus anthracis II. The immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infection, J. Infect. Dis., 80, 14, 10.1093/infdis/80.1.14 De, 1953, An experimental study of the mechanism of action of Vibrio cholerae on the intestinal mucous membrane, J. Pathol. Bacteriol., 66, 559, 10.1002/path.1700660228 Dorman, 2000, The activities of bacterial pathogens in vivo, Phil. Trans. R. Soc. Lond. B, 335, 547 Duesbery, 1998, Proteolytic inactivation of MAP-kinase by anthrax lethal factor, Science, 280, 734, 10.1126/science.280.5364.734 Eurich, 1930, vol. 5 Finkelstein, 1970, Production, purification and assay of cholera toxin, J. Infect. Dis., 121, S63, 10.1093/infdis/121.Supplement.S63 Gladstone, 1946, Immunity to anthrax protective antigen present in cell-free culture filtrates, Brit. J. Exp. Pathol., 27, 394 Harris-Smith, 1958, Production in vitro of the toxin of Bacillus anthracis previously recognized in vitro, J. Gen. Microbiol., 19, 91, 10.1099/00221287-19-1-91 Keppie, 1957, Lethality for guinea pigs of ultrasonic extracts of Pasteurella pestis; its relationship to death of guinea pigs from plague, Nature, 180, 1136, 10.1038/1801136a0 Keppie, 1953, The chemical basis of the virulence of Bacillus anthracis, II: some biological properties of bacterial products. Brit. J. Exp. Pathol., 34, 486 Keppie, 1955, The chemical basis of the virulence of Bacillus anthracis, III: The role of terminal bacteraemia in death of guinea pigs from anthrax. Brit. J. Exp. Pathol., 36, 315 King, 1950, The non-toxicity of Bacillus anthracis cell material, J. Gen. Microbiol., 4, 48, 10.1099/00221287-4-1-48 Leppla, 1991, The anthrax toxic complex, 277 McCartney, 1978, Mode of action of membrane-damaging toxins produced by staphylococci, 89 Mandrell, 1991, Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis, J. Bacteriol., 173, 2823, 10.1128/jb.173.9.2823-2832.1991 Mandrell, 1992, Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated, Infect. Immun., 60, 1322, 10.1128/IAI.60.4.1322-1328.1992 Meselson, 1994, The Svedlovsk anthrax outbreak of 1979, Science, 226, 1202, 10.1126/science.7973702 Mills, 1992, Lipopolysaccharide antigens of Camplyobacter jejuni, 223 Nairn, 1988, Cytidine 5'-monophospho-N-acetyl neuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum, J. Gen. Microbiol., 134, 3295 Smith, 1958, The use of bacteria grown in vivo for studies on the basis of their pathogenicity, Annu. Rev. Microbiol., 12, 77, 10.1146/annurev.mi.12.100158.000453 Smith, 1990, Pathogenicity and the microbe in vivo, J. Gen. Microbiol., 136, 377, 10.1099/00221287-136-3-377 Smith, 1954, Observations on experimental anthrax: demonstration of a specific lethal factor produced in vivo by Bacillus anthracis, Nature, 173, 869, 10.1038/173869a0 Smith, 1954, Observations on the cause of death in experimental anthrax, 474 Smith, 1953, A method for collecting bacteria and their products from infections in experimental animals, with special reference to Bacillus anthracis, Brit. J. Exp. Pathol., 34, 471 Smith, 1953, The chemical basis of the virulence of Bacillus anthracis, I: Properties of bacteria grown in vivo and preparation of extracts. Brit. J. Exp. Pathol., 34, 477 Smith, 1955, The chemical basis of the virulence of Bacillus anthracis, V. The specific toxin produced by B. anthracis in vivo. Brit. J. Exp. Pathol., 36, 460 Smith, 1955, The chemical basis of the virulence of Bacillus anthracis, IV: Secondary shock as the major factor in death of guinea pigs from anthrax. Brit. J. Exp. Pathol., 36, 323 Smith, 1962, Purification of the third factor of the anthrax toxin, J. Gen. Microbiol., 29, 517, 10.1099/00221287-29-3-517 Smith, 1956, The chemical basis of the virulence of Bacillus anthracis VII, Two components of the anthrax toxin: their relationship to known immunising aggressins. Brit. J. Exp. Pathol., 37, 263 Smith, 1962, Foetal erythritol: a cause of the tissue localization of Brucella abortus in bovine contagious abortion, Nature Lond., 193, 47, 10.1038/193047a0 Smith, 1971, Observations on the pathogenic properties of the K88, HYL and ENT plasmids of Escherichia coli with particular reference to diarrhoea, J. Med. Microbiol., 4, 467, 10.1099/00222615-4-4-467 Sobernheim, 1931, Vol. 3 Stanley, 1961, Purification of factor I and recognition of a third factor of the anthrax toxin, J. Gen. Microbiol., 26, 49, 10.1099/00221287-26-1-49 Stephen, 1981 Stoner, 1960 Strange, 1954, Studies on the protective antigen produced in vitro from Bacillus anthracis: purfication and chemistry of the antigen, Brit. J. Exp. Pathol., 35, 153 Thorne, 1960, Production of toxin in vitro by B. anthracis and its separation into two components, J. Bacteriol., 79, 450, 10.1128/JB.79.3.450-455.1960 Topley, 1936 Vitale, 1998, Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages, Biochem. Biophys. Res. Commun., 248, 706, 10.1006/bbrc.1998.9040 Weiss, 1982, The use of molecular techniques to study microbial determinants of pathogenicity, Phil. Trans. R. Soc. Lond. B, 303, 219, 10.1098/rstb.1983.0095 Woodin, 1970, Staphylococcal leucocidin., 327